V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008555 | 280005762 | 1.74 | null | Palliative (P) | 2017-02-20 | 2017-02-23 | Irinotecan + Modified De Gramont | null | null | 280028009 | VAI |
| 280008556 | 280005764 | 1.77 | 71 | Palliative (P) | 2014-08-16 | 2014-10-11 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280028015 | CETUXIMAB + CISPLATIN + FU |
| 280008557 | 280009020 | 1.76 | 72.4 | Palliative (P) | 2018-02-21 | 2018-02-21 | Cyclophosphamide oral | Y | N | 280028015 | CYCLOPHOSPHAMIDE |
| 280008558 | 280009020 | 1.63 | null | Adjuvant (A) | 2017-01-17 | 2017-07-01 | VAI (Ifos 3g/m2) | 02 | N | 280028015 | IRINOTECAN + MDG |
| 280008559 | 280005765 | 1.74 | null | Palliative (P) | 2017-09-05 | 2017-09-05 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 280028022 | CARBOPLATIN + PACLITAXEL |
| 280008560 | 280005765 | 1.6 | 43 | Palliative (P) | 2017-05-10 | 2017-05-12 | CARBOPLATIN + ETOPOSIDE | null | null | 280028022 | CARBOPLATIN + ETOPOSIDE |
| 280008561 | 280005767 | 1.67 | 54.3 | Palliative (P) | 2017-01-20 | 2017-02-12 | Carboplatin + Etoposide IV 3 day | N | N | 280028023 | CARBOPLATIN + ETOPOSIDE |
| 280008562 | 280005768 | 1.73 | 88.5 | Palliative (P) | 2013-07-21 | 2013-12-21 | Oxaliplatin + Modified de Gramont | N | N | 280028028 | OXALIPLATIN + MDG |
| 280008563 | 280005769 | 1.65 | 67.8 | Curative (C) | 2018-03-18 | 2018-04-02 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 280028030 | CISPLATIN + FLUOROURACIL |
| 280008564 | 280005770 | 1.76 | 52 | Neo-adjuvant (N) | 2018-04-25 | 2018-05-16 | CARBOPLATIN + ETOPOSIDE | N | N | 280028031 | CARBOPLATIN + ETOPOSIDE |
| 280008565 | 280009023 | 1.61 | 88.9 | Palliative (P) | 2015-02-28 | 2015-03-22 | Gemcitabine weekly | 2 | N | 280028032 | GEMCITABINE |
| 280008566 | 280005771 | 1.89 | 61.7 | Curative (C) | 2015-02-01 | 2015-02-01 | Doxorubicin + Ifosfamide | 02 | null | 280028032 | DOXORUBICIN + IFOSFAMIDE |
| 280008567 | 280005772 | 1.85 | null | Palliative (P) | 2016-10-14 | 2016-10-20 | DE-ESCALATE TRIAL | N | N | 280028044 | DE-ESCALATE TRIAL |
| 280008568 | 280005773 | 0 | 8.5 | Palliative (P) | 2017-06-10 | 2017-06-12 | DACTINOMYCIN + IFOSFAMIDE + MESNA + VINCRISTINE | N | N | 280028045 | IRINOTECAN + MDG |
| 280008569 | 280005773 | 0 | 59 | Palliative (P) | 2016-02-11 | 2016-02-26 | Irinotecan + Temozolomide | N | N | 280028045 | IRINOTECAN + TEMOZOLOMIDE |
| 280008570 | 280005774 | 1.61 | null | null | null | 2017-04-06 | Irinotecan + Modified De Gramont | null | null | 280028059 | VAI |
| 280008571 | 280005775 | 1.77 | null | Palliative (P) | 2015-03-06 | 2015-05-21 | Cyclophosphamide oral | 02 | N | 280028063 | CYCLOPHOSPHAMIDE |
| 280008572 | 280005777 | 1.61 | 66.6 | Palliative (P) | 2014-08-21 | 2014-09-22 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280028065 | CETUXIMAB + CISPLATIN + FU |
| 280008573 | 280005779 | 1.75 | null | Palliative (P) | 2013-06-19 | 2013-06-22 | VAC | 02 | N | 280028075 | CAV |
| 280008574 | 280005783 | null | 76 | Palliative (P) | 2015-07-15 | 2015-07-16 | EW Rel rEECur Irinotecan/Temozolomide | null | null | 280028080 | IRINOTECAN + MDG |
| 280008575 | 280005784 | 1.75 | 60.9 | Palliative (P) | 2017-11-22 | 2017-12-12 | CYCLOPHOSPHAMIDE | N | N | 280028083 | CYCLOPHOSPHAMIDE |
| 280008576 | 280005784 | null | 59.7 | Palliative (P) | 2016-04-13 | 2016-05-17 | CISPLATIN + GEMCITABINE | 2 | N | 280028083 | CISPLATIN + GEMCITABINE |
| 280008577 | 280005785 | 1.69 | 61.1 | Palliative (P) | 2013-11-07 | 2013-11-07 | Doxorubicin + Ifosfamide | N | N | 280028086 | DOXORUBICIN + IFOSFAMIDE |
| 280008578 | 280009030 | 1.73 | null | Palliative (P) | 2017-04-25 | 2017-04-25 | EURO-EWING | N | N | 280028090 | EURO-EWING |
| 280008579 | 280005789 | 1.85 | 69 | Neo-adjuvant (N) | 2016-11-15 | 2016-11-20 | VAI (Ifos 3g/m2) | N | N | 280028092 | IRINOTECAN + TEMOZOLOMIDE |
| 280008580 | 280005790 | null | 69.7 | Palliative (P) | 2015-03-22 | 2015-03-28 | CARBOPLATIN + PACLITAXEL | 2 | null | 280028094 | CARBOPLATIN + PACLITAXEL |
| 280008581 | 280005791 | 1.8 | null | Palliative (P) | 2018-01-08 | 2018-01-28 | Etoposide + Ifosfamide (3 days) | N | N | 280028096 | ETOPOSIDE + IFOSFAMIDE |
| 280008582 | 280005791 | 1.72 | 116.5 | Palliative (P) | 2016-08-17 | 2016-08-17 | VAC | 02 | N | 280028096 | CAV |
| 280008583 | 280011729 | 1.68 | 70 | Palliative (P) | 2015-02-22 | 2015-03-08 | DE-ESCALATE TRIAL | Y | N | 280028101 | DE-ESCALATE TRIAL |
| 280008584 | 280005793 | 1.63 | 75.6 | Palliative (P) | 2015-05-08 | 2015-05-20 | VAI (Ifos 3g/m2) | 02 | N | 280028106 | IRINOTECAN + TEMOZOLOMIDE |
| 280008585 | 280005793 | 1.72 | 97 | Palliative (P) | 2014-08-01 | 2014-08-21 | EW Rel rEECur Irinotecan/Temozolomide | 2 | N | 280028106 | IRINOTECAN + TEMOZOLOMIDE |
| 280008586 | 280005793 | 1.67 | null | null | 2016-07-01 | 2016-07-02 | DE-ESCALATE TRIAL | null | null | 280028106 | DE-ESCALATE TRIAL |
| 280008587 | 280005795 | 1.6 | null | Curative (C) | 2015-01-30 | 2015-03-31 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280028121 | CETUXIMAB + CISPLATIN + FU |
| 280008588 | 280005797 | 1.8 | 69.4 | Palliative (P) | 2015-11-05 | 2015-11-08 | EW EuroEwing 99 : VActI | N | null | 280028123 | EURO-EWING |
| 280008589 | 280005799 | 1.89 | 102.1 | Palliative (P) | 2016-10-03 | 2016-10-13 | CISPLATIN + GEMCITABINE | 2 | N | 280028129 | CISPLATIN + GEMCITABINE |
| 280008590 | 280005799 | 1.61 | null | Palliative (P) | 2015-12-31 | 2016-01-08 | Doxorubicin + Olaratumab | Y | N | 280028129 | DOXORUBICIN + OLARATUMAB |
| 280008591 | 280005799 | 1.65 | 58.75 | Palliative (P) | 2013-09-11 | 2013-10-05 | Carboplatin + Etoposide iv&po | 2 | N | 280028129 | CARBOPLATIN + ETOPOSIDE |
| 280008592 | 280005801 | 1.5 | 57 | Neo-adjuvant (N) | 2015-04-07 | 2015-04-15 | EW EuroEwing 99 : VIDE | N | N | 280028141 | EURO-EWING |
| 280008593 | 280005805 | null | 79 | Palliative (P) | 2015-09-26 | 2015-10-16 | EURO-EWING | 01 | N | 280028150 | EURO-EWING |
| 280008594 | 280005806 | 1.73 | null | null | 2017-12-02 | 2018-01-13 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280028151 | CISPLATIN + GEMCITABINE |
| 280008595 | 280009042 | 1.59 | 71 | Palliative (P) | 2017-09-17 | 2017-09-25 | CISPLATIN + FLUOROURACIL | 02 | null | 280028152 | CISPLATIN + FLUOROURACIL |
| 280008596 | 280005809 | 1.55 | null | Palliative (P) | 2016-07-15 | 2016-08-11 | Doxorubicin + Ifosfamide | null | null | 280028152 | DOXORUBICIN + IFOSFAMIDE |
| 280008597 | 280005809 | 1.86 | 108 | Palliative (P) | 2016-05-22 | 2016-06-24 | Carboplatin + Etoposide IV 3 day | Y | null | 280028152 | CARBOPLATIN + ETOPOSIDE |
| 280008598 | 280005810 | null | 75.65 | Palliative (P) | 2016-06-25 | 2016-06-29 | DE-ESCALATE TRIAL | N | N | 280028160 | DE-ESCALATE TRIAL |
| 280008599 | 280005811 | null | 61.1 | Palliative (P) | 2014-03-25 | 2014-03-25 | Etoposide + Ifosfamide (5 days) | N | null | 280028168 | ETOPOSIDE + IFOSFAMIDE |
| 280008600 | 280005811 | null | 84.6 | Neo-adjuvant (N) | 2018-02-18 | 2018-03-09 | GEMCITABINE | 02 | N | 280028168 | GEMCITABINE |
| 280008601 | 280005811 | 1.75 | 43 | Curative (C) | null | 2017-06-17 | Carboplatin + Etoposide IV 3 day | null | null | 280028168 | CARBOPLATIN + ETOPOSIDE |
| 280008602 | 280005812 | 1.69 | 71.4 | Palliative (P) | 2014-11-15 | 2014-11-16 | ETOPOSIDE + IFOSFAMIDE | 1 | N | 280028180 | ETOPOSIDE + IFOSFAMIDE |
| 280008603 | 280005814 | 1.79 | 73.2 | Curative (C) | 2014-09-19 | 2014-10-09 | EW Rel rEECur Irinotecan/Temozolomide | N | N | 280028182 | IRINOTECAN + TEMOZOLOMIDE |
| 280008604 | 280005818 | 1.58 | 64.8 | Adjuvant (A) | 2014-09-22 | 2014-11-04 | EW EuroEwing 99 : VActI | 02 | N | 280028183 | EURO-EWING |